Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $13K | conv 50First in 12mo | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $2.2K | conv 22Unusual size | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $25.5K | conv 86First in 12mo | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $5.7K | conv 23 | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $28.9K | conv 77First in 12mo | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $9.7K | conv 24 | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $12K | conv 74First in 12mo | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $219 | conv 21 | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $3.7K | conv 22Unusual size | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $21.8K | conv 32 | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $2.6K | conv 22 | SEC | |
ANADYS PHARMACEUTICALS INCListing unverified | Buy | $22.8K | conv 60First in 12mo | SEC |